Radiant HPV Shield—Protecting India's Daughters from Cervical Cancer
Keywords:
radiant shield, young girls, cervical cancerAbstract
Every five minutes, one woman in India dies from cervical cancer; 123,000 women die each year due to cervical cancer, approximately 26% of the global cervical cancer burden. Most cases occur in rural areas, where access to essential healthcare is limited. There are currently very low rates of HPV vaccination in India (1.3% from the NFHS-5 study), and despite the development of a promising HPV vaccine, Cervavac. This exclusion from UIP is heartbreaking. We need to act now by leveraging successful pilots, as those in Sikkim, to bridge this gap and save lives
Downloads
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49.
International Institute for Population Sciences (IIPS) and ICF. National Family Health Survey (NFHS-5), India, 2019-21. Mumbai: IIPS; 2021.
Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Wang X, et al. India Source: Global Cancer Observatory: Cancer Today [Internet]. Lyon: International Agency for Research on Cancer; 2022 [cited 2026 Feb 14]. Available from: https://gco.iarc.who.int/today.
Sankaran S, Kumar R, Singh A. Human papillomavirus (HPV) vaccine introduction in Sikkim state: Opportunities and challenges. 2022;34(2):45-50.
World Health Organization. One-dose human papillomavirus (HPV) vaccine offers solid protection against cervical cancer. Wkly Epidemiol Rec. 2022;97(21):285-300.
Published
How to Cite
License
Copyright (c) 2026 Dr Aswathy Madhu, Kajal Srivastava, Dr.Swati Ghonge
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
